Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' COOKFAIR D' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 10 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Goodkin, DE; Reingold, S; Sibley, W; Wolinsky, J; McFarland, H; Cookfair, D; Lublin, F
      Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: Reporting extended results from Phase III clinical trials

      ANNALS OF NEUROLOGY
    2. FISCHER JS; PRIORE R; JACOBS L; COOKFAIR D; RUDICK R; HERNDON R; RICHERT J; SALAZAR A; GOODKIN D; GRANGER C; SIMON J; GRAFMAN J; LEZAK M; OREILLY K; SCHACTER M; SHUCARD D; DAVIDSON A; WENDE K
      NEUROPSYCHOLOGICAL EFFECTS OF AVONEX(R) (INTERFERON-BETA-1A) IN RELAPSING MULTIPLE-SCLEROSIS (MS)

      Neurology
    3. RUDICK R; COOKFAIR D; SIMON J; SIMONIAN N; JACOBS L; HERNDON R; RICHERT J; SALAZAR A; FISCHER J; GRANGER C; GOODKIN D; OREILLY K; BOYLE S
      CSF KAPPA-LIGHT-CHAINS AND GADOLINIUM-ENHANCING BRAIN-LESIONS AS PREDICTORS OF RESPONSE TO THERAPY WITH INTERFERON-BETA 1A (AVONEX(R)) IN PATIENTS WITH RELAPSING MULTIPLE-SCLEROSIS

      Neurology
    4. RUDICK RA; JONES W; ALAM J; SIMONIAN N; CAMPION M; JACOBS L; HERNDON R; RICHERT J; SALAZAR A; COOKFAIR D; SIMON J; COATS M; GOODKIN D; MASS M
      SIGNIFICANCE OF SERUM NEUTRALIZING ANTIBODIES TO AVONEX' (IFN-BETA-1A) IN MULTIPLE-SCLEROSIS

      Neurology
    5. LUBLIN FD; REINGOLD SC; CLANET M; COOKFAIR D; EBERS G; GOODKIN D; HARTUNG HP; LISAK R; MCDONALD WI; MCFARLAND H; NOSEWORTHY J; PANITCH H; POLMAN C; REDER A; RUDGE P; SIBLEY W; WHITAKER J; WOLINSKY J
      GUIDELINES FOR CLINICAL-TRIALS OF NEW THERAPEUTIC AGENTS IN MULTIPLE-SCLEROSIS - RELATIONS BETWEEN STUDY INVESTIGATORS, ADVISERS, AND SPONSORS

      Neurology
    6. RUDICK RA; JACOBS L; ALAM J; COOKFAIR D; HERNDON R; RICHERT J; SALAZAR A; FISCHER J; GOODKIN D; GRANGER C; SIMON J
      TOXICITY OF RECOMBINANT INTRAMUSCULAR RECOMBINANT INTERFERON-BETA-1A IN MULTIPLE-SCLEROSIS PATIENTS

      Annals of neurology
    7. SIMON JH; JACOBS L; COOKFAIR D; RUDICK R; HERNDON R; SALAZAR A; RICHERT J; CHOI K; FISCHER J; GOODKIN D; GRANGER C
      THE NATURAL-HISTORY OF MS BASED ON AN ANNUAL MR SNAPSHOT - RESULTS FROM THE MSCRG STUDY OF INTRAMUSCULAR RECOMBINANT INTERFERON-BETA-1A

      Neurology
    8. INSKIP PD; EBY NL; COOKFAIR D; FREEDMAN RS; RICHARDSON GS; WACTAWSKIWENDE J; HOOVER RN; BOICE JD
      SERUM ESTROGEN AND ANDROGEN LEVELS FOLLOWING TREATMENT FOR CERVICAL-CANCER

      Cancer epidemiology, biomarkers & prevention
    9. JACOBS L; COOKFAIR D; RUDICK R; HERNDON R; RICHERT J; SALAZAR A; FISCHER J; GRANGER C; SIMON J; GOODKIN D
      RESULTS OF A PHASE-III TRIAL OF INTRAMUSCULAR RECOMBINANT BETA-INTERFERON AS TREATMENT FOR MULTIPLE-SCLEROSIS

      Annals of neurology
    10. JACOBS L; COOKFAIR D; RUDICK R; HERNDON R; SALAZAR A; RICHERT J; FISCHER J; GOODKIN D; GRANGER C; SIMON J; EMRICH L
      A PHASE-III TRIAL OF INTRAMUSCULAR RECOMBINANT INTERFERON-BETA AS TREATMENT FOR MULTIPLE-SCLEROSIS - CURRENT STATUS

      Annals of neurology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 18:35:04